Literature DB >> 32402727

Cardiac Rehabilitation Quality in Australia: Proposed National Indicators for Field-Testing.

Robyn Gallagher1, Emma Thomas2, Carolyn Astley3, Rachelle Foreman2, Cate Ferry4, Robert Zecchin5, Steve Woodruffe6.   

Abstract

Mesh：

Year:  2020        PMID： 32402727     DOI： 10.1016/j.hlc.2020.02.014

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN： 1443-9506            Impact factor:   2.975


× No keyword cloud information.
  3 in total

1.  Assessing the quality of cardiac rehabilitation programs by measuring adherence to the Australian quality indicators.

Authors:  C M Astley; A Beleigoli; R Tavella; J Hendriks; C Gallagher; R Tirimacco; G Wilson; T Barry; R A Clark
Journal:  BMC Health Serv Res       Date:  2022-02-28       Impact factor: 2.908

2.  Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol.

Authors:  Alline Beleigoli; Stephen J Nicholls; Alex Brown; Derek P Chew; John Beltrame; Anthony Maeder; Carol Maher; Vincent L Versace; Jeroen M Hendriks; Philip Tideman; Billingsley Kaambwa; Christopher Zeitz; Ivanka J Prichard; Rosanna Tavella; Rosy Tirimacco; Wendy Keech; Carolyn Astley; Kay Govin; Katie Nesbitt; Huiyun Du; Stephanie Champion; Maria Alejandra Pinero de Plaza; Imelda Lynch; Vanessa Poulsen; Marie Ludlow; Ken Wanguhu; Hendrika Meyer; Ali Krollig; Lemlem Gebremichael; Chloe Green; Robyn A Clark
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 3.006

3.  The Impact of the SARS-CoV-2 Virus (COVID-19) Pandemic and the Rapid Adoption of Telehealth for Cardiac Rehabilitation and Secondary Prevention Programs in Rural and Remote Australia: A Multi-Method Study.

Authors:  Stephanie Champion; Robyn A Clark; Rosy Tirimacco; Philip Tideman; Lemlem Gebremichael; Alline Beleigoli
Journal:  Heart Lung Circ       Date:  2022-08-17       Impact factor: 2.838
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.